相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Distinct Expression Profiles of p63 Variants during Urothelial Development and Bladder Cancer Progression
Orit Karni-Schmidt et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
miR-205 Expression Levels in Nonsmall Cell Lung Cancer Do Not Always Distinguish Adenocarcinomas From Squamous Cell Carcinomas
Valerio Del Vescovo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens: Utility of an Immunohistochemical Panel Containing TTF-1, Napsin A, p63, and CK5/6
Sanjay Mukhopadhyay et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Immunohistochemical Subtyping of Nonsmall Cell Lung Cancer Not Otherwise Specified in Fine-Needle Aspiration Cytology A Retrospective Study of 103 Cases With Surgical Correlation
Luisella Righi et al.
CANCER (2011)
Utility of 10 Immunohistochemical Markers Including Novel Markers (Desmocollin-3, Glypican 3, S100A2, S100A7, and Sox-2) for Differential Diagnosis of Squamous Cell Carcinoma from Adenocarcinoma of the Lung
Koji Tsuta et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer
Giorgio Scagliotti et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens
Natasha Rekhtman et al.
MODERN PATHOLOGY (2011)
Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component
Akihiko Yoshida et al.
LUNG CANCER (2011)
Pathological Diagnosis and Classification of Lung Cancer in Small Biopsies and Cytology: Strategic Management of Tissue for Molecular Testing
William D. Travis et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Mutations in the DDR2 Kinase Gene identify a Novel therapeutic target in squamous cell lung cancer
Peter S. Hammerman et al.
CANCER DISCOVERY (2011)
Optimal Immunohistochemical Markers For Distinguishing Lung Adenocarcinomas From Squamous Cell Carcinomas in Small Tumor Samples
Jefferson Terry et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
p63 in Epithelial Survival, Germ Cell Surveillance, and Neoplasia
Christopher P. Crum et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Accurate Classification of Non-Small Cell Lung Carcinoma Using a Novel MicroRNA-Based Approach
Justin A. Bishop et al.
CLINICAL CANCER RESEARCH (2010)
Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens
Peh Sun Loo et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation Analysis
Andrew G. Nicholson et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
Jonathan Weiss et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Comparison of Thyroid Transcription Factor-1 Expression by 2 Monoclonal Antibodies in Pulmonary and Nonpulmonary Primary Tumors
Andres Matoso et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2010)
p63 Protein expression in high risk diffuse large B-cell lymphoma
A. E. Hallack Neto et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung
Valentina Monica et al.
MODERN PATHOLOGY (2009)
Expression of p63 in anaplastic large cell lymphoma but not in classical Hodgkin's lymphoma
Gabriela Gualco et al.
HUMAN PATHOLOGY (2008)
Immunohistochemical detection of XIAP and p63 in adenomatous hyperplasia, atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and well-differentiated adenocarcinoma
Maoxin Wu et al.
MODERN PATHOLOGY (2008)
The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas
Aydanur Kargi et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)
p63 is essential for the proliferative potential of stem cells in stratified epithelia
Makoto Senoo et al.
CELL (2007)
Clinico-pathological characteristics of p63 expression in B-cell lymphoma
Noriyasu Fukushima et al.
CANCER SCIENCE (2006)
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas
A Zamò et al.
MODERN PATHOLOGY (2005)
Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers
MX Wu et al.
DIAGNOSTIC CYTOPATHOLOGY (2005)
Expression of p63 in reactive hyperplasias and malignant lymphomas
CK Park et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2005)
Expression of p63 in diffuse large B-cell lymphoma
CV Hedvat et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2005)
The transactivating isoforms of p63 are overexpressed in high-grade follicular lymphomas independent of the occurrence of p63 gene amplification
G Pruneri et al.
JOURNAL OF PATHOLOGY (2005)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations
IM Shih et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
p63 expression in lung carcinoma - A tissue microarray study of 408 cases
NHC Au et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2004)
Dominant negative p63 isoform expression in head and neck squamous cell carcinoma
JC Sniezek et al.
LARYNGOSCOPE (2004)
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
DH Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The role of p63 and ΔNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis
H Geddert et al.
HUMAN PATHOLOGY (2003)
Constitutive expression of ΔN-p63α isoform in human thymus and thymic epithelial tumours
M Chilosi et al.
VIRCHOWS ARCHIV (2003)
Differential expression of p63 isoforms in normal tissues and neoplastic cells
K Nylander et al.
JOURNAL OF PATHOLOGY (2002)
Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis:: The role of ΔN-p63
M Chilosi et al.
LABORATORY INVESTIGATION (2002)
p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
G Pelosi et al.
JOURNAL OF PATHOLOGY (2002)
Primary anaplastic large cell lymphoma of the lung: A clinicopathologic study of five patients
WL Rush et al.
MODERN PATHOLOGY (2000)
AIS is an oncogene amplified in squamous cell carcinoma
K Hibi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
